Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.
Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R. Keefer MC, et al. Among authors: dekker c. AIDS Res Hum Retroviruses. 1996 May 20;12(8):683-93. doi: 10.1089/aid.1996.12.683. AIDS Res Hum Retroviruses. 1996. PMID: 8744579 Clinical Trial.
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers.
Kahn JO, Sinangil F, Baenziger J, Murcar N, Wynne D, Coleman RL, Steimer KS, Dekker CL, Chernoff D. Kahn JO, et al. Among authors: dekker cl. J Infect Dis. 1994 Nov;170(5):1288-91. doi: 10.1093/infdis/170.5.1288. J Infect Dis. 1994. PMID: 7963729 Clinical Trial.
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.
Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, Handsfield HH, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE. Corey L, et al. Among authors: dekker cl. JAMA. 1999 Jul 28;282(4):331-40. doi: 10.1001/jama.282.4.331. JAMA. 1999. PMID: 10432030 Clinical Trial.
Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers.
Black SB, Shinefield HR, Bergen R, Hart C, Kremers R, Lavetter A, Lemesurier J, Morozumi PA, Ray P, Lewis EM, Fireman B, Schwalbe J, Hallam P, Shandling M, Dekker C, Granoff DM, Izu A, Podda A. Black SB, et al. Among authors: dekker c. Pediatr Infect Dis J. 1997 Jan;16(1):53-8. doi: 10.1097/00006454-199701000-00012. Pediatr Infect Dis J. 1997. PMID: 9002102 Clinical Trial.
525 results